News for TG Therapeutics, Inc. (0VGI.L)

On March 5, 2025, Opaleye Management Inc. (Trades, Portfolio) made a strategic move by acquiring an additional 260,000 shares of Codexis Inc. (CDXS). This trans

**media[555305]**

TG Therapeutics Inc (TGTX) has announced its schedule for presenting data from the ULTIMATE I & II Phase 3 trials and the ENHANCE Phase 3b trial on BRIUMVI® (u

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. ( TGTX), today announced the schedule of presentations highlighting data from the ULTIMATE I

On December 31, 2024, Opaleye Management Inc. (Trades, Portfolio) executed a significant transaction involving Ocular Therapeutix Inc. The firm reduced its hold

**media[538355]**

TG Therapeutics to use MaxCyte's Flow Electroporation® technology and ExPERTâ„¢ platform to support the development and commercialization of azer-cel, its all

In our monthly Rare Stock Picks series, we're highlighting January 2025 investment picks. Click here for the list of January 2025 Buy recommendations.

On January 22, 2025, Opaleye Management Inc. (Trades, Portfolio) executed a substantial reduction in its holdings of Harrow Inc., a U.S.-based eyecare pharmaceu

TG Therapeutics is entering 2025 with investors accustomed to a beat-and-raise guidance policy and the company needs to deliver. Learn more on TGTX stock here.

We recently compiled a list of the 12 Hot Stocks to Buy According to Analysts. In this article, we are going to take a look at where TG Therapeutics, Inc.

We recently published an article titled 10 Firms Post Impressive Gains on Tuesday. In this article, we are going to take a look at where TG Therapeutics Inc.

TG Therapeutics, Inc. (TGTX), Tuesday announced preliminary fourth-quarter and full year 2024 results of Briumvi, a novel monoclonal antibody used for the treatment of relapsing forms of multiple sclerosis in adults.

**media[514523]**

Shares of Yum China Holdings Inc YUMC rose sharply in today's pre-market trading after the company reported better-than-expected third-quarter EPS and revenues....

Overview of Recent Transaction On November 1, 2024, Opaleye Management Inc. (Trades, Portfolio) made a significant addition to its investment portfolio by acqui

Shares of Nikola Corporation NKLA fell sharply in Monday's session after the company announced it entered into a securities purchase agreement and filed for a m...

Discover 21 new analysts who joined Seeking Alpha in June.

Global Multiple Sclerosis Drugs Market Size Projected to Reach $38 Billion By 2032 as Demand on R&D for Developing Innovative Drugs Rises